Literature DB >> 8545643

Intravenous methylmethacrylate following cemented total hip arthroplasty.

E Brandser1, G el-Khoury, M Riley, J Callaghan.   

Abstract

Both cemented and noncemented techniques have been used for total hip arthroplasty (THA). Each technique has advantages and disadvantages. Among the disadvantages of cemented THA are several perioperative complications, such as intraoperative cardiac or respiratory failure and hypotension, called "cement implantation syndrome," and extrusion of cement beyond the confines of the medullary canal. Cement extrusion can be the result of overreaming of the femoral canal and cortical perforation. This is a worrisome finding, as the risk of subsequent femoral fracture at the site of perforation is increased. Extruded cement, however, does not always indicate a problem. Extruded cement located within the femoral venous system, intravenous methylmethacrylate, for example, is not associated with long-term complications. While uncommon, it is important to differentiate this finding from the more serious cortical perforation. We report four examples of intravenous methylmethacrylate following THA and describe the imaging features that allow differentiation of this entity from the more significant finding of cortical perforation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8545643     DOI: 10.1007/bf00202143

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  8 in total

1.  Problem prostheses: the radiologic evaluation of total joint replacement.

Authors:  D N Rabin; C Smith; R A Kubicka; S Rabin; A Ali; J R Charters; H Rabin
Journal:  Radiographics       Date:  1987-11       Impact factor: 5.333

2.  Intramedullary pressure and pulmonary embolism of femoral medullary contents in dogs during insertion of bone cement and a prosthesis.

Authors:  T Kallos; J E Enis; F Gollan; J H Davis
Journal:  J Bone Joint Surg Am       Date:  1974-10       Impact factor: 5.284

3.  Fat embolism during total hip replacement. A prospective study.

Authors:  J H Herndon; C O Bechtol; D P Crickenberger
Journal:  J Bone Joint Surg Am       Date:  1974-10       Impact factor: 5.284

4.  Cardiopulmonary function and pulmonary microemboli during arthroplasty using cemented or non-cemented components. The role of intramedullary pressure.

Authors:  E C Orsini; R J Byrick; J B Mullen; J C Kay; J P Waddell
Journal:  J Bone Joint Surg Am       Date:  1987-07       Impact factor: 5.284

5.  Loosening of the femoral component after use of the medullary-plug cementing technique. Follow-up note with a minimum five-year follow-up.

Authors:  W H Harris; W A McGann
Journal:  J Bone Joint Surg Am       Date:  1986-09       Impact factor: 5.284

6.  Intravenous methylmethacrylate after total hip replacement.

Authors:  B N Weissman; J L Sosman; E M Braunstein; H Dadkhahipoor; K Kandarpa; T S Thornhill; J D Lowell; C B Sledge
Journal:  J Bone Joint Surg Am       Date:  1984-03       Impact factor: 5.284

7.  Cemented versus noncemented total hip arthroplasty--embolism, hemodynamics, and intrapulmonary shunting.

Authors:  M H Ereth; J G Weber; M D Abel; R L Lennon; D G Lewallen; D M Ilstrup; K Rehder
Journal:  Mayo Clin Proc       Date:  1992-11       Impact factor: 7.616

8.  Results of revision for mechanical failure after cemented total hip replacement, 1979 to 1982. A two to five-year follow-up.

Authors:  J J Callaghan; E A Salvati; P M Pellicci; P D Wilson; C S Ranawat
Journal:  J Bone Joint Surg Am       Date:  1985-09       Impact factor: 5.284

  8 in total
  2 in total

1.  Bone cement (PMMA) arterio-venogram following total hip arthroplasty - Case series.

Authors:  Hemanth Kumar Venkatesh; Mohammad Shoaib
Journal:  J Clin Orthop Trauma       Date:  2017-08-30

2.  Polymethylmethacrylate extrusion into the femoral nutrient vessel during arthroplasty: A phenomenon to be aware of.

Authors:  Peter J Smitham; Caroline Perkins; Martin Williams; Steve Eastaugh-Waring
Journal:  J Radiol Case Rep       Date:  2009-02-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.